The long term objective of the proposed research is to develop a clinically useful measure of tumor hypoxia. Tumor hypoxia can compromise the effectiveness of radiation treatment because of the well-known radioresistance of hypoxic cells. Tumor hypoxia is also seen as a target for selective chemotherapy with hypoxic cell cytotoxins. Rational intervention directed at hypoxic cells using hyperbaric oxygen, hypoxic cell radiosensitizers or hypoxic cell cytotoxins is confounded by the absence of a practical way of measuring hypoxia in individual tumors in particular patients. This grant proposes that hypoxic cell markers can serve this purpose. In the absence of oxygen, cellular redox enzymes activate nitroaromatic compounds in a way which leads to their irreversible binding to cellular proteins. The bound molecules becomes markers of cellular hypoxia. When suitably labelled, the markers can be detected by autoradiography, gamma ray scintigraphy, positron emission tomography, magnetic resonance spectroscopy or immunohistochemistry. In the immunohistochemical approach proposed, fluorescent antibody reagents clamp onto a marker molecule bound to cellular protein. The presence of hypoxia in sections of tumor tissue is then revealed upon fluorescence microscopic examination. The feasibility of using this approach to measure tumor hypoxia has been established in preliminary studies.
The specific aims of the proposed research include optimizing the immunohistochemical approach for application in tumors of canine patients with a view to establishing a basis for early clinical application of immunohistochemistry to the measure of tumor hypoxia on an individual tumor basis.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
5R01CA050995-02
Application #
3195605
Study Section
Radiation Study Section (RAD)
Project Start
1990-02-01
Project End
1993-01-31
Budget Start
1991-02-01
Budget End
1992-01-31
Support Year
2
Fiscal Year
1991
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
Schools of Medicine
DUNS #
078861598
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Olive, Peggy L; Banath, Judit P; Durand, Ralph E (2002) The range of oxygenation in SiHa tumor xenografts. Radiat Res 158:159-66
Olive, P L; Luo, C-M; Banath, J P (2002) Local hypoxia is produced at sites of intratumour injection. Br J Cancer 86:429-35
Olive, P L; Banath, J P; Aquino-Parsons, C (2001) Measuring hypoxia in solid tumours--is there a gold standard? Acta Oncol 40:917-23
Olive, P L; Aquino-Parsons, C; MacPhail, S H et al. (2001) Carbonic anhydrase 9 as an endogenous marker for hypoxic cells in cervical cancer. Cancer Res 61:8924-9
Rijken, P F; Bernsen, H J; Peters, J P et al. (2000) Spatial relationship between hypoxia and the (perfused) vascular network in a human glioma xenograft: a quantitative multi-parameter analysis. Int J Radiat Oncol Biol Phys 48:571-82
Olive, P L; Durand, R E; Raleigh, J A et al. (2000) Comparison between the comet assay and pimonidazole binding for measuring tumour hypoxia. Br J Cancer 83:1525-31
Arteel, G E; Kadiiska, M B; Rusyn, I et al. (1999) Oxidative stress occurs in perfused rat liver at low oxygen tension by mechanisms involving peroxynitrite. Mol Pharmacol 55:708-15
Raleigh, J A; Chou, S C; Arteel, G E et al. (1999) Comparisons among pimonidazole binding, oxygen electrode measurements, and radiation response in C3H mouse tumors. Radiat Res 151:580-9
Zhong, Z; Arteel, G E; Connor, H D et al. (1999) Binge drinking disturbs hepatic microcirculation after transplantation: prevention with free radical scavengers. J Pharmacol Exp Ther 290:611-20
Durand, R E; Raleigh, J A (1998) Identification of nonproliferating but viable hypoxic tumor cells in vivo. Cancer Res 58:3547-50

Showing the most recent 10 out of 26 publications